Paul Jacob, DO
Adult Reconstructive Orthopaedic Surgery · Oklahoma City, OKNPI 1548433345
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $704,739 of the $821,991 with a category attached, or 85.7%. Stryker accounts for 97.0% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $206,576, 2.6 times the $78,952 reported in 2019.
Across 918 payments — averaging $895.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$798K
- B. Braun Medical Inc.$10K
- Pacira Therapeutics, Inc.$5K
- Orthosensor Inc.$4K
- KCI USA, Inc.$2K
- Medtronic$1K
- plus $2K from 20 others
Across 6 payments — averaging $6883.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$41K
What the payments were for
- Consulting fees$704,73986%
- Travel & lodging$97,90412%
- Food & beverage$19,3482%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 851 | $797,645 |
| B. Braun Medical Inc. | 1 | $10,000 |
| Pacira Therapeutics, Inc. | 6 | $5,083 |
| Orthosensor Inc. | 15 | $4,410 |
| KCI USA, Inc. | 2 | $1,617 |
| Medtronic | 6 | $1,384 |
| Think Surgical, Inc. | 2 | $310 |
| Zimmer Biomet | 3 | $265 |
| Conmed Corporation | 4 | $236 |
| Arthrex | 2 | $206 |
| Bone Support Inc. | 1 | $134 |
| Johnson & Johnson | 4 | $106 |
| Pylant Medical | 3 | $90 |
| Heron Therapeutics, Inc. | 2 | $80 |
| Smith+Nephew | 2 | $71 |
| Paragon 28, Inc. | 1 | $68 |
| Biotissue Holdings Inc. | 2 | $65 |
| Avanos Medical | 1 | $50 |
| Pacira Pharmaceuticals Incorporated | 2 | $45 |
| Molnlycke Health Care US, LLC | 2 | $26 |
| Heraeus Medical, LLC. | 1 | $26 |
| Amgen | 1 | $19 |
| Vertex | 1 | $19 |
| Deroyal Industries, Inc. | 1 | $15 |
| Aesculap Implant Systems, LLC | 1 | $14 |
| Omnilife Science, Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$730,304
- ACCOLADE$35,825
- TRIATHLON$24,419
- PRONTOSAN$10,000
- MOTIONSENSE DIGITAL GONIOMETER$8,125
- INSIGNIA$6,325
- GMRS$5,665
- Zilretta$5,000
- AEQUALIS$3,850
- Verasense$3,581
- TRITANIUM$3,014
- ORTHOLOGIQ$2,800
- PREVENA$1,600
- HOFFMANN$1,498
- Arctic Front$1,260
- MOTIONSENSE$400
- TMINI Miniature Robotic System$310
- ZIPSEAL 16 SURGICAL SKIN CLOSURE KIT$165
- ZIPSEAL 24 SURGICAL SKIN CLOSURE KIT$165
- ZIP DS DRESSING SHIELD$165
How this compares
Too few adult reconstructive orthopaedic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $26,514 |
| ZilrettaTriamcinolone Acetonide | 26 | $20,401 |
| Naloxone Hcl | 254 | $15,866 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 544 | $8,699 |
| Tranexamic Acid | 241 | $6,468 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 294 | $4,540 |
| Doxycycline Hyclate | 433 | $4,250 |
| Famotidine | 474 | $2,307 |
| Doxycycline Monohydrate | 58 | $1,625 |
| Tizanidine Hcl | 321 | $1,293 |
| Ibuprofen | 283 | $1,112 |
| Dexamethasone | 255 | $1,000 |
| Amoxicillin | 534 | $899 |
| ErythromycinErythromycin Base | 29 | $821 |
| Hydroxyzine Pamoate | 132 | $811 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Pacira Pharmaceuticals IncorporatedZilretta | $45 | $20,40126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult reconstructive orthopaedic surgery providers in Oklahomaon file to place this against a meaningful peer group, so we don't.
Other adult reconstructive orthopaedic surgery in Oklahoma City
- Corey PonderOklahoma City$291K
- Kyle McGivernOklahoma City$19K
- Jacob HaynesOklahoma City$17K
- Rishi ThakralOklahoma City$9K
- John TompkinsOklahoma City$450
- Scott DunitzTulsa$186K
- Zackary BurrowTulsa$17K
- James SlaterTulsa$7K
- Ronald LabuttiTulsa$6K
- Christian LuessenhopTulsa$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.